900 related articles for article (PubMed ID: 15995743)
21. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
22. Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.
Reisner E; Arion VB; Eichinger A; Kandler N; Giester G; Pombeiro AJ; Keppler BK
Inorg Chem; 2005 Sep; 44(19):6704-16. PubMed ID: 16156629
[TBL] [Abstract][Full Text] [Related]
23. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F
Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730
[TBL] [Abstract][Full Text] [Related]
24. Electronic structures of ruthenium and osmium complexes of 9,10-phenanthrenequinone.
Biswas MK; Patra SC; Maity AN; Ke SC; Adhikary ND; Ghosh P
Inorg Chem; 2012 Jun; 51(12):6687-99. PubMed ID: 22663598
[TBL] [Abstract][Full Text] [Related]
25. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.
Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E
Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366
[TBL] [Abstract][Full Text] [Related]
26. Ruthenium(II) complexes containing bis(2-(diphenylphosphino)phenyl) ether and their catalytic activity in hydrogenation reactions.
Venkateswaran R; Mague JT; Balakrishna MS
Inorg Chem; 2007 Feb; 46(3):809-17. PubMed ID: 17257024
[TBL] [Abstract][Full Text] [Related]
27. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
[TBL] [Abstract][Full Text] [Related]
29. Osmium NAMI-A analogues: synthesis, structural and spectroscopic characterization, and antiproliferative properties.
Cebrián-Losantos B; Krokhin AA; Stepanenko IN; Eichinger R; Jakupec MA; Arion VB; Keppler BK
Inorg Chem; 2007 Jun; 46(12):5023-33. PubMed ID: 17497853
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
[TBL] [Abstract][Full Text] [Related]
31. Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
Büchel GE; Gavriluta A; Novak M; Meier SM; Jakupec MA; Cuzan O; Turta C; Tommasino JB; Jeanneau E; Novitchi G; Luneau D; Arion VB
Inorg Chem; 2013 Jun; 52(11):6273-85. PubMed ID: 23659478
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.
Groessl M; Reisner E; Hartinger CG; Eichinger R; Semenova O; Timerbaev AR; Jakupec MA; Arion VB; Keppler BK
J Med Chem; 2007 May; 50(9):2185-93. PubMed ID: 17402720
[TBL] [Abstract][Full Text] [Related]
33. Ru(II) complexes containing dmso and pyrazolyl ligands as catalysts for nitrile hydration in environmentally friendly media.
Ferrer Í; Rich J; Fontrodona X; Rodríguez M; Romero I
Dalton Trans; 2013 Oct; 42(37):13461-9. PubMed ID: 23896601
[TBL] [Abstract][Full Text] [Related]
34. The unprecedented bridging coordination mode of 1,1-cyclobutane dicarboxylate (mu-cbdc-O,O') stabilized by intramolecular hydrogen bonds in ruthenium(II) complexes.
Bratsos I; Zangrando E; Serli B; Katsaros N; Alessio E
Dalton Trans; 2005 Dec; (24):3881-5. PubMed ID: 16311642
[TBL] [Abstract][Full Text] [Related]
35. New cationic and neutral Ru(II)- and Os(II)-dmso carbonyl compounds.
Bratsos I; Calmo S; Zangrando E; Balducci G; Alessio E
Inorg Chem; 2013 Oct; 52(20):12120-30. PubMed ID: 24090044
[TBL] [Abstract][Full Text] [Related]
36. Ruthenium complexes of C,C'-bis(ethynyl)carboranes: an investigation of electronic interactions mediated by spherical pseudo-aromatic spacers.
Fox MA; Roberts RL; Baines TE; Guennic BL; Halet JF; Hartl F; Yufit DS; Albesa-Jové D; Howard JA; Low PJ
J Am Chem Soc; 2008 Mar; 130(11):3566-78. PubMed ID: 18293977
[TBL] [Abstract][Full Text] [Related]
37. Heteroleptic tris-chelates of ruthenium(II): synthesis, spectral characterisation and electrochemical properties.
Byabartta P
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Mar; 66(3):521-33. PubMed ID: 17029945
[TBL] [Abstract][Full Text] [Related]
38. A new family of mono- and dicarboxylic ruthenium complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): synthesis, solution behavior, and X-ray molecular structure of trans-[Ru(DIP)2(MeOH)2][OTf]2.
Caspar R; Cordier C; Waern JB; Guyard-Duhayon C; Gruselle M; Le Floch P; Amouri H
Inorg Chem; 2006 May; 45(10):4071-8. PubMed ID: 16676968
[TBL] [Abstract][Full Text] [Related]
39. Trans-cis-cis-[RuCl2(DMSO)2(2-amino-5-methyl-thiazole)2], (PMRu52), a novel ruthenium(II) compound acting as a strong inhibitor of cathepsin B.
Mura P; Camalli M; Casini A; Gabbiani C; Messori L
J Inorg Biochem; 2010 Feb; 104(2):111-7. PubMed ID: 19939460
[TBL] [Abstract][Full Text] [Related]
40. En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].
Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Keppler BK; Arion VB
Inorg Chem; 2011 Aug; 50(16):7690-7. PubMed ID: 21739939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
